On Tuesday, in the course of current trade, Shares of KCG Holdings, Inc. (NYSE:KCG), dropped -1.16%, and is now trading at $12.81.
KCG Holdings, released trade volumes for the month of May 2015.
In Market Making, KCG averaged $27.5 billion dollar volume traded, 5.5 billion shares traded, and 3.5 million trades per day in U.S. equities.
In Global Execution Services:
- KCG electronic execution averaged 279.1 million shares traded per day in U.S. equities
- KCG BondPoint averaged $144.0 million per day in fixed income par value
KCG Holdings, Inc., an independent securities firm, provides various services designed to address trading needs across asset classes, product types, and time zones. The company operates through three segments: Market Making, Global Execution Services, and Corporate and Other.
During an Afternoon trade, Shares of Sealed Air Corp (NYSE:SEE), climbed 2.14%, and is now trading at $50.66.
Sealed Air Corp, declared the pricing of its offering of $400 million aggregate principal amount of 5.500% senior unsecured notes due 2025 and €400 million aggregate principal amount of 4.500% senior unsecured notes due 2023. Sealed Air intends to use the net proceeds from the offering of the Notes to repurchase, redeem or satisfy and discharge all of its outstanding 8.375% Senior Notes due 2021, counting any premiums, fees and expenses in connection therewith. Net proceeds from the sale of the Dollar Notes and the Euro Notes, after initial purchasers’ discounts and commissions and the Company’s estimated fees and expenses, are predictable to be about $395 million and €395 million, respectively. We expect the offering to close on June 16, 2015, subject to customary closing conditions.
Sealed Air Corporation provides food safety and security, facility hygiene, and product protection solutions worldwide. The company’s Food Care segment offers integrated system solutions that incorporate equipment systems into customers operations; and packaging equipment systems that incorporate various options for loading, filling and dispensing, and retort and aseptic processing conditions.
Shares of NextEra Energy Inc (NYSE:NEE), during its Tuesday’s current trading session raised 0.30%, and is now trading at $99.44.
NextEra Energy, declared the completion of a 2.6 MW solar system on the main college campus in Dryden, New York. The system, installed on about 10 acres, is predictable to meet 90 percent of the college’s electricity needs.
“We’re proud to support TC3’s aims to be more energy efficient and to save money that can be applied to programs for students,” said Matt Handel, vice president of development for NextEra Energy Resources. “By putting a piece of their underutilized land to work generating clean solar energy, TC3 will receive competitively priced electricity at no up-front cost.”
NextEra Energy, Inc., through its auxiliaries, generates, transmits, and distributes electric energy in the United States and Canada. The company generates electricity from gas, oil, solar, coal, petroleum coke, nuclear, and wind sources.
Finally, Sequenom, Inc. (NASDAQ:SQNM), gained 0.3% Tuesday, hitting its highest level.
Sequenom, declared that it has reached separate, privately negotiated exchange agreements with certain holders of its outstanding 5.00% Convertible Senior Notes due 2017 issued on September 17, 2012 following which Sequenom will exchange $85 million in aggregate principal amount of the Existing Notes for $85 million in aggregate principal amount of new 5.00% Convertible Exchange Senior Notes due 2018. Following the closing of these transactions, $45 million in aggregate principal amount of the Existing Notes will remain outstanding with terms unchanged. The exchange was predictable to close on June 9, 2015, subject to customary closing conditions.
The New Notes will accrue interest at an annual rate of 5.00%, payable semi-annually in arrears in cash on April 1 and October 1 of each year, startning October 1, 2015. The New Notes will mature on January 1, 2018, unless formerly repurchased or exchanged in accordance with their terms preceding to such date.
Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women’s health and oncology markets in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.